Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2025-12-26 @ 3:44 AM
NCT ID: NCT00796718
Description: All enrolled participants.
Frequency Threshold: 5
Time Frame: Up to 15 weeks
Study: NCT00796718
Study Brief: A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Capecitabine Capecitabine 825 mg/m\^2 orally twice daily plus standard radiotherapy for 5 weeks as prescribed according to normal clinical practice, followed by surgery within 6 weeks after completion of treatment. None None 4 62 49 62 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Ventricular fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (19.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Hemorrhoidal inflammation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Ileus SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (19.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (19.0) View
Rectal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Dermatitis radiation SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (19.0) View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (19.0) View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (19.0) View
Leukopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (19.0) View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (19.0) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (19.0) View
Upper respiratory infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (19.0) View
Cyst in the liver SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (19.0) View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (19.0) View
Palmar-plantar erythrodysesthesia syndrome SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (19.0) View